🔗 Permalink

Inventor profile of:

Ryuji UENO

City:

Potomac, Maryland

Country:

United States

Published Applications:

Last publication date:

2015-01-01

Top Assignees for applications by Ryuji UENO

The entities that hold a legal rights for patent applications filed by inventor UENO Ryuji:

SUCAMPO AG 42 Zug, Switzerland
R-TECH UENO, LTD. 15 Tokyo, Japan
R-TECH UENO, LTD. 5 Chiyoda-ku, Japan
Sucampo AG 4 Zurich, Switzerland
RUSK INTELLECTUAL RESERVE AG 3 Zug, Switzerland
VLP THERAPEUTICS, LLC 1 Wilmington, DE United States
Astellas Pharma Inc. 1 Chuo-ku, Japan
R-TECH UENO, LTD. 1 Tokyo-to, Japan
Sumcampo AG 1 Zug, Switzerland
Rusk Intellecutal Reserve AG 1 Zug, Switzerland

Recent patent applications by UENO Ryuji

Ryuji UENO from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-01-01

US20150005381A1

Chemistry; metallurgy

METHOD FOR MODULATING STEM CELL GROWTH

#2 | 2014-12-18

US20140371309A1

Human necessities

OPHTHALMIC SOLUTION

#3 | 2014-10-23

US20140315994A1

Chemistry; metallurgy

METHOD FOR TREATING GASTROINTESTINAL DISORDER

#4 | 2014-09-25

US20140287036A1

Human necessities

SOFT-GELATIN CAPSULE FORMULATION

#5 | 2014-08-21

US20140235665A1

Chemistry; metallurgy

ANTI-CONSTIPATION COMPOSITION

#6 | 2014-07-10

US20140194497A1

Chemistry; metallurgy

COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT

#7 | 2014-06-19

US20140171496A1

Human necessities

COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH

#8 | 2014-05-15

US20140131121A1

Performing operations; transporting

ELECTRIC VEHICLE AND ELECTRIC SUPPLY ARRANGEMENT FOR THE SAME

#9 | 2014-03-06

US20140066506A1

Human necessities

METHOD FOR TREATING MACULAR DEGENERATION

#10 | 2014-02-06

US20140039058A1

Human necessities

Ophthalmic solution

#11 | 2014-01-30

US20140031428A1

Chemistry; metallurgy

METHOD FOR TREATING SCHIZOPHRENIA

#12 | 2013-10-24

US20130281638A1

Chemistry; metallurgy

TRICYCLO COMPOUND-POLYMER CONJUGATE

#13 | 2013-10-24

US20130281637A1

Human necessities

Fatty acid derivative-polymer conjugate

#14 | 2013-10-24

US20130281526A1

Human necessities

METHOD FOR TREATING IRRITABLE BOWEL SYNDROME WITH DIARRHEA

#15 | 2013-09-26

US20130251744A1

Chemistry; metallurgy

Virus like particle composition

#16 | 2013-08-22

US20130217770A1

Chemistry; metallurgy

METHOD FOR TREATING IRRITABLE BOWEL SYNDROME BY ADMINISTRATION OF CHLORIDE CHANNEL OPENER

#17 | 2013-06-06

US20130143958A1

Chemistry; metallurgy

DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION

#18 | 2013-03-28

US20130078303A1

Human necessities

Soft-gelatin capsule formulation

#19 | 2013-02-07

US20130035393A1

Chemistry; metallurgy

Method for treating schizophrenia

#20 | 2013-01-03

US20130005995A1

Chemistry; metallurgy

Method for preparing a fatty acid derivative

#21 | 2012-10-18

US20120263803A1

Human necessities

AQUEOUS OPHTHALMIC COMPOSITION

#22 | 2012-09-20

US20120237598A1

Chemistry; metallurgy

Anti-constipation composition

#23 | 2012-09-06

US20120225938A1

Chemistry; metallurgy

METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

#24 | 2012-04-19

US20120095090A1

Human necessities

NOVEL COMPOSITION AND METHOD FOR STABILIZING THE SAME

#25 | 2012-04-12

US20120088824A1

Chemistry; metallurgy

Dosage unit comprising a prostaglandin analog for treating constipation

#26 | 2012-04-12

US20120088823A1

Chemistry; metallurgy

COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT

#27 | 2012-01-26

US20120022152A1

Chemistry; metallurgy

Anti-constipation composition

#28 | 2012-01-17

US13289386

Composition and method for stabilizing the same

#29 | 2011-12-08

US20110300211A1

Human necessities

Soft-gelatin capsule formulation

#30 | 2011-10-06

US20110244037A1

Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A BI-CYCLIC COMPOUND AND METHOD FOR STABILIZING THE BI-CYCLIC COMPOUND

#31 | 2011-10-06

US20110244036A1

Human necessities

Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound

#32 | 2011-08-04

US20110186368A1

Performing operations; transporting

Electric vehicle and electric supply arrangement for the same

#33 | 2011-03-17

US20110065784A1

Human necessities

Method for promoting upper gastrointestinal bicarbonate secretion

#34 | 2010-11-25

US20100298424A1

Chemistry; metallurgy

METHOD FOR TREATING ABDOMINAL DISCOMFORT

#35 | 2010-10-28

US20100274032A1

Chemistry; metallurgy

Method for preparing prostaglandin derivative

#36 | 2010-10-21

US20100267832A1

Human necessities

Method for treating macular degeneration

#37 | 2010-08-12

US20100204491A1

Chemistry; metallurgy

Method for preparing prostaglandin derivative

#38 | 2010-08-12

US20100204489A1

Chemistry; metallurgy

Method for preparing prostaglandin derivative

#39 | 2010-08-12

US20100204332A1

Human necessities

METHOD FOR TREATING A DISEASE OR CONDITION RESPONSIVE TO OPENING OF C1C-2 CHANNEL

#40 | 2009-11-12

US20090281711A1

Mechanical engineering

Energy-efficient automobile

#41 | 2008-05-22

US20080119462A1

Human necessities

METHOD FOR TREATING VASCULAR HYPERPERMEABLE DISEASE

#42 | 2008-03-20

US20080070979A1

Human necessities

Method for promoting gastrointestinal bicarbonate secretion

#43 | 2007-10-18

US20070244333A1

Chemistry; metallurgy

Method for preparing prostaglandin derivative

#44 | 2007-07-26

US20070172523A1

Human necessities

Soft-gelatin capsule formulation

#45 | 2007-07-26

US20070172522A1

Human necessities

Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound

#46 | 2006-04-25

US10187013

Composition for topical administration

#47 | 2006-02-16

US20060034892A1

Human necessities

Composition for topical administration

#48 | 2005-11-24

US20050261373A1

Human necessities

Prostaglandin compounds for the treatment of obesity

#49 | 2005-10-06

US20050222265A1

Human necessities

Ophthalmic solution

#50 | 2005-10-06

US20050222195A1

Chemistry; metallurgy

Anti-constipation composition

#51 | 2005-03-29

US10354083

Use of macrolide compounds for the treatment of dry eye

#52 | 2005-03-08

US9869129

Agent for treating visual cell function disorder

InventorID:

14801 ⎘